Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Geng, Shuang ^a   Zhong, Yiwei ^b   Wang, Shuang ^a   Liu, Hu ^a   Zou, Qiang ^a   Xie, Xiaoping ^a   Li, Chaofan ^a   Yu, Qingling ^c   He, Zhonghuai ^c   Wang, Bin ^a,b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Beijing Advaccine Biotechnology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CD8 ANTIGEN; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRANZYME B; HEPATITIS B VACCINE; GRANZYME; GZMB PROTEIN, MOUSE; PERFORIN, MOUSE; PORE FORMING CYTOTOXIC PROTEIN; SODIUM CHANNEL BLOCKING AGENT;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC TRANSDUCTION; HEPATITIS B; HEPATITIS B VIRUS; HOST CELL; HYPERTENSION; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTRACELLULAR TRANSPORT; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PLASMID; PRESCRIPTION; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS ENTRY; ANIMAL; C57BL MOUSE; CELL LINE; CELLULAR IMMUNITY; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; TRANSGENIC MOUSE;

HEPATITIS B VIRUS;

ADAPTIVE IMMUNITY; AMILORIDE; ANIMALS; CELL LINE; FEMALE; GRANZYMES; HEPATITIS B VACCINES; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PLASMIDS; PORE FORMING CYTOTOXIC PROTEINS; SODIUM CHANNEL BLOCKERS; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC; VACCINES, DNA;

EID: 84863380419     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033015     Document Type: Article

References (49)

1. Coney L, Wang B, Ugen KE, Boyer J, McCallus D, et al. (1994) Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 12: 1545-1550.
2. Brown SE, Stanley C, Howard CR, Zuckerman AJ, Steward MW, (1986) Antibody responses to recombinant and plasma derived hepatitis B vaccines. Br Med J (Clin Res Ed) 292: 159-161.
3. Donnelly JJ, Wahren B, Liu MA, (2005) DNA vaccines: progress and challenges. J Immunol 175: 633-639.
4. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA, (1997) DNA vaccines. Annu Rev Immunol 15: 617-648.
5. Gurunathan S, Klinman DM, Seder RA, (2000) DNA vaccines: immunology, application, and optimization*. Annu Rev Immunol 18: 927-974.
6. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, et al. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90: 11478-11482.
7. Rocha-Zavaleta L, Alejandre JE, Garcia-Carranca A, (2002) Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses. J Med Virol 66: 86-95.
8. Belperron AA, Feltquate D, Fox BA, Horii T, Bzik DJ, (1999) Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum. Infect Immun 67: 5163-5169.
9. Leitner WW, Baker MC, Berenberg TL, Lu MC, Yannie PJ, et al. (2009) Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen. Blood 113: 37-45.
10. Hirao LA, Wu L, Khan AS, Satishchandran A, Draghia-Akli R, et al. (2008) Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. Vaccine 26: 440-448.
11. Smith KA, Tam VL, Wong RM, Pagarigan RR, Meisenburg BL, et al. (2009) Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 27: 2603-2615.
12. Widera G, Austin M, Rabussay D, Goldbeck C, Barnett SW, et al. (2000) Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164: 4635-4640.
13. Aberle JH, Aberle SW, Allison SL, Stiasny K, Ecker M, et al. (1999) A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol 163: 6756-6761.
14. Pilling AM, Harman RM, Jones SA, McCormack NA, Lavender D, et al. (2002) The assessment of local tolerance, acute toxicity, and DNA biodistribution following particle-mediated delivery of a DNA vaccine to minipigs. Toxicol Pathol 30: 298-305.
15. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, et al. (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 90: 4156-4160.
16. Koivusalo M, Welch C, Hayashi H, Scott CC, Kim M, et al.Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 188: 547-563.
17. Gong Q, Weide M, Huntsman C, Xu Z, Jan LY, et al. (2007) Identification and characterization of a new class of trafficking motifs for controlling clathrin-independent internalization and recycling. J Biol Chem 282: 13087-13097.
18. Hood SJ, Taylor KP, Ashby MJ, Brown MJ, (2007) The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation 116: 268-275.
19. Rejman J, Conese M, Hoekstra D, (2006) Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J Liposome Res 16: 237-247.
20. Ignatovich IA, Dizhe EB, Pavlotskaya AV, Akifiev BN, Burov SV, et al. (2003) Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways. J Biol Chem 278: 42625-42636.
21. Qian ZM, Li H, Sun H, Ho K, (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54: 561-587.
22. Di Fabio S, Mbawuike IN, Kiyono H, Fujihashi K, Couch RB, et al. (1994) Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells. Int Immunol 6: 11-19.
23. Wan Y, Lu L, Bramson JL, Baral S, Zhu Q, et al. (2001) Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8(+) CTL in vivo. J Immunol 167: 5027-5033.
24. Chattopadhyay PK, Betts MR, Price DA, Gostick E, Horton H, et al. (2009) The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 85: 88-97.
25. Johnson BJ, Costelloe EO, Fitzpatrick DR, Haanen JB, Schumacher TN, et al. (2003) Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci U S A 100: 2657-2662.
26. Shacklett BL, Cox CA, Quigley MF, Kreis C, Stollman NH, et al. (2004) Abundant expression of granzyme A, but not perforin, in granules of CD8+ T cells in GALT: implications for immune control of HIV-1 infection. J Immunol 173: 641-648.
27. Makedonas G, Hutnick N, Haney D, Amick AC, Gardner J, et al. (2010) Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 6: e1000798.
28. Makedonas G, Banerjee PP, Pandey R, Hersperger AR, Sanborn KB, et al. (2009) Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity. J Immunol 182: 5560-5569.
29. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, et al. (2009) Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10: 29-37.
30. Jeng RL, Welch MD, (2001) Cytoskeleton: actin and endocytosis-no longer the weakest link. Curr Biol 11: R691-694.
31. Qualmann B, Kessels MM, (2002) Endocytosis and the cytoskeleton. Int Rev Cytol 220: 93-144.
32. Lanzetti L, Di Fiore PP, Scita G, (2001) Pathways linking endocytosis and actin cytoskeleton in mammalian cells. Exp Cell Res 271: 45-56.
33. Ondrej V, Lukasova E, Falk M, Kozubek S, (2007) The role of actin and microtubule networks in plasmid DNA intracellular trafficking. Acta Biochim Pol 54: 657-663.
34. Geiger RC, Taylor W, Glucksberg MR, Dean DA, (2006) Cyclic stretch-induced reorganization of the cytoskeleton and its role in enhanced gene transfer. Gene Ther 13: 725-731.
35. Yang Z, Sahay G, Sriadibhatla S, Kabanov AV, (2008) Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem 19: 1987-1994.
36. Vandenbroucke RE, Lucas B, Demeester J, De Smedt SC, Sanders NN, (2007) Nuclear accumulation of plasmid DNA can be enhanced by non-selective gating of the nuclear pore. Nucleic Acids Res 35: e86.
37. Karkada M, Weir GM, Quinton T, Fuentes-Ortega A, Mansour M, (2010) A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery. Vaccine 28: 6176-6182.
38. Nomura T, Nakajima S, Kawabata K, Yamashita F, Takakura Y, et al. (1997) Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer. Cancer Res 57: 2681-2686.
39. Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X, et al. (2001) Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res 61: 3281-3284.
40. Haddad D, Ramprakash J, Sedegah M, Charoenvit Y, Baumgartner R, et al. (2000) Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J Immunol 165: 3772-3781.
41. Donnelly JJ, Liu MA, Ulmer JB, (2000) Antigen presentation and DNA vaccines. Am J Respir Crit Care Med 162: S190-193.
42. Paul L, Porgador A, (2000) DNA-based vaccines: role of dendritic cells in antigen presentation. Adv Exp Med Biol 479: 175-184.
43. Rice J, King CA, Spellerberg MB, Fairweather N, Stevenson FK, (1999) Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. Vaccine 17: 3030-3038.
44. Feltquate DM, (1998) DNA vaccines: vector design, delivery, and antigen presentation. J Cell Biochem (Suppl 30-31): 304-311.
45. Weissman D, Ni H, Scales D, Dude A, Capodici J, et al. (2000) HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol 165: 4710-4717.
46. Shedlock DJ, Weiner DB, (2000) DNA vaccination: antigen presentation and the induction of immunity. J Leukoc Biol 68: 793-806.
47. Du X, Zheng G, Jin H, Kang Y, Wang J, et al. (2007) The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 9: 136-146.
48. Piriou L, Chilmonczyk S, Genetet N, Albina E, (2000) Design of a flow cytometric assay for the determination of natural killer and cytotoxic T-lymphocyte activity in human and in different animal species. Cytometry 41: 289-297.
49. Schirmbeck R, Stober D, El-Kholy S, Riedl P, Reimann J, (2002) The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes. J Immunol 168: 6253-6262.